GWM
DFTX icon

GK Wealth Management’s Definium Therapeutics DFTX Stock Holding History

GK Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.7K Buy
+360
New +$15.2K 0.01% 755

Other funds holding DFTX

SCI
Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
BWM
Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GK Wealth Management's DFTX Position: Q3 2026 in Review

GK Wealth Management opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 360 shares worth $13.7K. The stake represents 0.01% of the portfolio and ranks #755 among its holdings.

8 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • GK Wealth Management held 360 shares of Definium Therapeutics worth $13.7K as of Q3 2026.
  • Definium Therapeutics was a new GK Wealth Management position in Q3 2026.
  • Definium Therapeutics made up 0.01% of GK Wealth Management's portfolio in Q3 2026, its #755 holding.
  • 8 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.